OPRM1 and respiratory depression: However, although MOR G-protein biased agonist were design in order to enhance and/or to prolong antinociception and to decrease tolerance, some recent studies point out controversial results for respiratory depression, constipation or withdrawal (Hill et al., 2018; Kliewer et al., 2019, 2020).